Ke Y - Search Results

1

Reduced glutathione ameliorates liver function, oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma.

Ke Y, Wu T, Lei X, Zhang C, Zhou J, Li J, Zhang H, Chen X, Wang J, Wang L. Ke Y, et al. J BUON. 2020 May-Jun;25(3):1361-1367. J BUON. 2020. PMID: 32862577 Free article.

2

Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension.

Zhong JH, Ke Y, Wang YY, Li LQ. Zhong JH, et al. Among authors: ke y. Gut. 2015 Mar;64(3):520-1. doi: 10.1136/gutjnl-2014-308139. Epub 2014 Sep 3. Gut. 2015. PMID: 25187522 No abstract available.

3

Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection.

Ke Y, Wang L, Li LQ, Zhong JH. Ke Y, et al. World J Hepatol. 2014 Sep 27;6(9):652-9. doi: 10.4254/wjh.v6.i9.652. World J Hepatol. 2014. PMID: 25276281 Free PMC article. Review.

4

Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Zhong JH, Rodríguez AC, Ke Y, Wang YY, Wang L, Li LQ. Zhong JH, et al. Among authors: ke y. Medicine (Baltimore). 2015 Jan;94(3):e396. doi: 10.1097/MD.0000000000000396. Medicine (Baltimore). 2015. PMID: 25621684 Free PMC article. Review.

5

Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival.

Yang XD, Pan LH, Wang L, Ke Y, Cao J, Yang C, Zhong JH, Luo W, Guo J, Li LQ. Yang XD, et al. Among authors: ke y. Asian Pac J Cancer Prev. 2015;16(13):5541-7. doi: 10.7314/apjcp.2015.16.13.5541. Asian Pac J Cancer Prev. 2015. PMID: 26225708 Free article. Review.

6

Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.

Shi Z, Wu X, Ke Y, Wang L. Shi Z, et al. Among authors: ke y. Dig Dis Sci. 2016 Mar;61(3):785-94. doi: 10.1007/s10620-015-3927-y. Epub 2015 Oct 31. Dig Dis Sci. 2016. PMID: 26520111

7

Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.

Wu XS, Bao TH, Ke Y, Sun DY, Shi ZT, Tang HR, Wang L. Wu XS, et al. Among authors: ke y. Tumour Biol. 2016 Nov;37(11):14711-14719. doi: 10.1007/s13277-016-5336-z. Epub 2016 Sep 14. Tumour Biol. 2016. PMID: 27623945

8

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.

Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ. Zhong JH, et al. Among authors: ke y. Onco Targets Ther. 2016 Nov 10;9:6897-6907. doi: 10.2147/OTT.S120062. eCollection 2016. Onco Targets Ther. 2016. PMID: 27877054 Free PMC article.

9

Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.

Ke Y, Bao T, Wu X, Tang H, Wang Y, Ge J, Fu B, Meng X, Chen L, Zhang C, Tan Y, Chen H, Guo Z, Ni F, Lei X, Shi Z, Wei D, Wang L. Ke Y, et al. Biochem Biophys Res Commun. 2017 Jan 29;483(1):509-515. doi: 10.1016/j.bbrc.2016.12.114. Epub 2016 Dec 18. Biochem Biophys Res Commun. 2017. PMID: 27998773

10

The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis.

Lei X, Wang F, Ke Y, Wei D, Gu H, Zhang Z, Jiang L, Lv L, Lin J, Wang L. Lei X, et al. Among authors: ke y. Medicine (Baltimore). 2017 Mar;96(10):e6301. doi: 10.1097/MD.0000000000006301. Medicine (Baltimore). 2017. PMID: 28272258 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,285 results

Search Page

Filters